Show simple item record

Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

dc.contributor.authorAdams, Paul
dc.contributor.authorAltes, Albert
dc.contributor.authorBrissot, Pierre
dc.contributor.authorButzeck, Barbara
dc.contributor.authorCabantchik, Ioav
dc.contributor.authorCançado, Rodolfo
dc.contributor.authorDistante, Sonia
dc.contributor.authorEvans, Patricia
dc.contributor.authorEvans, Robert
dc.contributor.authorGanz, Tomas
dc.contributor.authorGirelli, Domenico
dc.contributor.authorHultcrantz, Rolf
dc.contributor.authorMcLaren, Gordon
dc.contributor.authorMarris, Ben
dc.contributor.authorMilman, Nils
dc.contributor.authorNemeth, Elizabeta
dc.contributor.authorNielsen, Peter
dc.contributor.authorPineau, Brigitte
dc.contributor.authorPiperno, Alberto
dc.contributor.authorPorto, Graça
dc.contributor.authorPrince, Dianne
dc.contributor.authorRyan, John
dc.contributor.authorSanchez, Mayka
dc.contributor.authorSantos, Paulo
dc.contributor.authorSwinkels, Dorine
dc.contributor.authorTeixeira, Emerência
dc.contributor.authorToska, Ketil
dc.contributor.authorVanclooster, Annick
dc.contributor.authorWhite, Desley
dc.contributor.authorContributors and Hemochromatosis International Taskforce
dc.date.accessioned2024-01-31T14:10:44Z
dc.date.available2024-01-31T14:10:44Z
dc.date.issued2018
dc.identifier.citationAdams, Paul; Altes, Albert; Brissot, Pierre [et al.]. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype. Hepatology International, 2018, 12, p. 83-86. Disponible en: <https://link.springer.com/article/10.1007/s12072-018-9855-0>. Fecha de acceso: 31 ene. 2024. DOI: 10.1007/s12072-018-9855-0ca
dc.identifier.issn1936-0533ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/3996
dc.description.abstractAlthough guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.ca
dc.format.extent3ca
dc.language.isoengca
dc.publisherSpringer Natureca
dc.relation.ispartofHepatology Internationalca
dc.relation.ispartofseries12
dc.rights© 2018 Springer Natureca
dc.subject.otherMedicinaca
dc.subject.otherMedicineca
dc.titleTherapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotypeca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc61ca
dc.identifier.doihttps://dx.doi.org/10.1007/s12072-018-9855-0ca


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint